Published in J Exp Med on March 17, 2008
Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol (2011) 6.96
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med (2008) 4.38
Innate immunity in the central nervous system. J Clin Invest (2012) 2.77
Trafficking of immune cells in the central nervous system. J Clin Invest (2010) 2.17
Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol (2009) 2.16
Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab (2009) 1.97
Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity (2009) 1.95
Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One (2010) 1.73
CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat Neurosci (2010) 1.65
GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. J Exp Med (2010) 1.52
Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J Neurosci (2009) 1.41
T(H)17 cytokines in autoimmune neuro-inflammation. Curr Opin Immunol (2011) 1.40
The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta (2010) 1.40
Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol Rev (2012) 1.39
EAE mediated by a non-IFN-γ/non-IL-17 pathway. Eur J Immunol (2010) 1.39
Highly polarized Th17 cells induce EAE via a T-bet independent mechanism. Eur J Immunol (2013) 1.30
Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J Immunol (2010) 1.30
Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J Neurosci (2010) 1.28
Th17 cells in autoimmune demyelinating disease. Semin Immunopathol (2010) 1.27
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. J Clin Invest (2014) 1.24
Neutrophils in innate and adaptive immunity. Semin Immunopathol (2013) 1.23
A protective role for ELR+ chemokines during acute viral encephalomyelitis. PLoS Pathog (2009) 1.23
Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum (2010) 1.23
Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol (2011) 1.22
FoxP3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes. J Immunol (2010) 1.15
Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp Neurol (2009) 1.14
Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am J Pathol (2008) 1.08
IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis. J Immunol (2009) 1.08
Neutrophil-related factors as biomarkers in EAE and MS. J Exp Med (2015) 1.06
RTL therapy for multiple sclerosis: a Phase I clinical study. J Neuroimmunol (2010) 1.04
A NET Outcome. Front Immunol (2012) 1.00
Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis. Mediators Inflamm (2014) 0.97
CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis. J Neuroinflammation (2012) 0.95
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy? Front Immunol (2012) 0.93
Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller? J Neuroimmunol (2012) 0.93
Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis. J Immunol (2014) 0.92
Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin. J Immunol (2012) 0.92
The inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis. PLoS Pathog (2014) 0.92
CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. PLoS One (2010) 0.92
Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. Br J Pharmacol (2012) 0.92
Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation. Am J Pathol (2009) 0.91
G protein-coupled receptors as therapeutic targets for multiple sclerosis. Cell Res (2012) 0.90
Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination. Mol Psychiatry (2014) 0.89
CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function. J Neuroimmunol (2011) 0.89
Preferential Recruitment of Neutrophils into the Cerebellum and Brainstem Contributes to the Atypical Experimental Autoimmune Encephalomyelitis Phenotype. J Immunol (2015) 0.88
Functional defect of peripheral neutrophils in mice with induced deletion of CXCR2. Genesis (2013) 0.87
Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice. J Neurosci (2015) 0.86
Microbial induction of vascular pathology in the CNS. J Neuroimmune Pharmacol (2010) 0.86
ELR(+) chemokine signaling in host defense and disease in a viral model of central nervous system disease. Front Cell Neurosci (2014) 0.86
Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis. J Immunol (2014) 0.86
Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice. J Exp Med (2016) 0.86
α(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro. J Cell Physiol (2012) 0.85
HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice. J Immunol (2009) 0.85
Regulation of suppressors of cytokine signaling as a therapeutic approach in autoimmune diseases, with an emphasis on multiple sclerosis. J Signal Transduct (2011) 0.84
Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice. ASN Neuro (2012) 0.84
IFN-γ protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils. J Neuroinflammation (2012) 0.84
Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis. Front Neurol (2013) 0.83
CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia. PLoS One (2013) 0.82
IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP). PLoS One (2015) 0.81
Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis. J Neuroinflammation (2015) 0.81
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis. Front Neurosci (2015) 0.81
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications. Mediators Inflamm (2016) 0.79
Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy. PLoS One (2013) 0.79
Neutrophil contribution to spinal cord injury and repair. J Neuroinflammation (2014) 0.79
β₂-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations. J Neuroinflammation (2014) 0.79
The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice. Int J Nanomedicine (2014) 0.78
Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis. BMC Med (2012) 0.78
Immune mediators of chronic pelvic pain syndrome. Nat Rev Urol (2014) 0.78
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells. Nat Commun (2016) 0.77
The chemokine receptor CXCR2 and coronavirus-induced neurologic disease. Virology (2013) 0.77
Type 1 Diabetes Prone NOD Mice Have Diminished Cxcr1 mRNA Expression in Polymorphonuclear Neutrophils and CD4+ T Lymphocytes. PLoS One (2015) 0.77
CXCR2 signaling and host defense following coronavirus-induced encephalomyelitis. Future Virol (2012) 0.77
DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation. Brain (2014) 0.77
Neuronal I kappa B kinase beta protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system. J Immunol (2009) 0.77
Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity. J Neurochem (2015) 0.77
Neutrophils in animal models of autoimmune disease. Semin Immunol (2016) 0.76
Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System. Stem Cells Transl Med (2015) 0.76
Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease. J Neurosci (2017) 0.75
Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF). Sci Rep (2016) 0.75
T-bet promotes the accumulation of encephalitogenic Th17 cells in the CNS. J Neuroimmunol (2016) 0.75
Neutrophils and viral-induced neurologic disease. Clin Immunol (2016) 0.75
Spatiotemporal ablation of CXCR2 on oligodendrocyte lineage cells: Role in myelin repair. Neurol Neuroimmunol Neuroinflamm (2015) 0.75
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders. ACS Med Chem Lett (2016) 0.75
The contribution of neutrophils to CNS autoimmunity. Clin Immunol (2016) 0.75
Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res (2002) 28.38
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol (2005) 27.17
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature (2003) 22.89
Interleukin-17 family members and inflammation. Immunity (2004) 16.16
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol (2006) 10.33
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med (2002) 8.33
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain (2002) 6.85
Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science (1994) 5.20
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler (1999) 4.91
Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med (1994) 4.16
The neutrophil as a cellular source of chemokines. Immunol Rev (2000) 4.09
IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J Immunol (2000) 2.76
CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J Immunol (1999) 2.56
Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med (2001) 2.45
Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol (2001) 2.38
Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J Immunol (2003) 2.18
Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol (1995) 2.13
Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp Med (2005) 2.12
Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol (2006) 2.12
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain (2005) 2.07
Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth. J Biol Chem (2000) 1.99
Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol (1998) 1.91
Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol (1996) 1.90
Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol (1997) 1.88
CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol (2001) 1.76
CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J Immunol (2001) 1.73
Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol (1998) 1.72
Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol (2006) 1.67
Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J Immunol (1998) 1.60
Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J Immunol (2003) 1.60
Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol (1985) 1.52
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42
CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr Biol (1998) 1.41
T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis. Am J Pathol (2004) 1.39
Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain (1997) 1.37
Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience (1996) 1.36
Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem (2002) 1.30
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. J Immunol (2002) 1.27
Groalpha-mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity. Eur J Immunol (1999) 1.26
Signaling via beta(2) integrins triggers neutrophil-dependent alteration in endothelial barrier function. J Exp Med (2000) 1.23
Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J Cereb Blood Flow Metab (2003) 1.21
Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr Opin Immunol (2006) 1.19
Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J Clin Invest (1996) 1.13
Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest (1982) 1.11
Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol (2001) 1.04
A critical role for mouse CXC chemokine(s) in pulmonary neutrophilia during Th type 1-dependent airway inflammation. J Immunol (2001) 1.02
Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression. J Neuroimmunol (2000) 1.00
Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation (1998) 0.97
Increased CXCL8 (IL-8) expression in Multiple Sclerosis. J Neuroimmunol (2004) 0.96
Molecular targets in radiation-induced blood-brain barrier disruption. Int J Radiat Oncol Biol Phys (2005) 0.94
Neutral proteases and disruption of the blood-brain barrier in rat. Brain Res (1997) 0.94
Neutrophils induce sequential focal changes in endothelial adherens junction components: role of elastase. Microcirculation (2003) 0.91
Kinetics of leukocyte-induced changes in endothelial barrier function. Br J Pharmacol (1998) 0.88
Measurement of vascular permeability in spinal cord using Evans Blue spectrophotometry and correction for turbidity. J Neurosci Methods (1995) 0.85
Degradation of microvascular brain endothelial cell beta-catenin after co-culture with activated neutrophils from patients undergoing cardiac surgery with prolonged cardiopulmonary bypass. Biochem Biophys Res Commun (2005) 0.83
IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol (2002) 4.81
Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science (2005) 3.32
Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe (2012) 2.66
Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol (2006) 2.53
Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci U S A (2010) 2.00
G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood (2011) 1.82
Chitinase dependent control of protozoan cyst burden in the brain. PLoS Pathog (2012) 1.68
CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat Neurosci (2010) 1.65
Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J Neurosci (2010) 1.40
Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol (2006) 1.38
Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp Neurol (2003) 1.35
Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol (2003) 1.33
Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol (2004) 1.31
Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A (2011) 1.30
Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J Neurosci (2010) 1.28
Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. Eur J Immunol (2006) 1.25
A protective role for ELR+ chemokines during acute viral encephalomyelitis. PLoS Pathog (2009) 1.23
Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinase. J Immunol (2004) 1.22
CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy. Eur J Immunol (2008) 1.22
Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp Neurol (2004) 1.21
CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J Immunol (2006) 1.20
Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. J Gen Virol (2006) 1.13
Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci U S A (2006) 1.10
CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection. J Virol (2003) 1.09
Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. Mult Scler (2004) 1.08
Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol (2011) 1.07
Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology (2004) 1.06
The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun (2006) 1.04
Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol (2002) 1.04
Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response. Exp Neurol (2005) 1.03
Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease. J Virol (2003) 1.00
The role of chemokines during viral infection of the CNS. PLoS Pathog (2010) 1.00
T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Blood (2007) 1.00
The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun (2006) 0.99
Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease. J Immunol (2007) 0.97
Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system. Autoimmunity (2007) 0.96
CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination. Glia (2011) 0.96
Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system. Virology (2003) 0.96
Surgical transplantation of mouse neural stem cells into the spinal cords of mice infected with neurotropic mouse hepatitis virus. J Vis Exp (2011) 0.95
Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections. J Virol (2012) 0.95
Cutting edge: the chemokine receptor CXCR3 retains invariant NK T cells in the thymus. J Immunol (2009) 0.95
T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection. J Immunol (2006) 0.95
NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis. J Virol (2007) 0.94
Impaired immune responses following spinal cord injury lead to reduced ability to control viral infection. Exp Neurol (2010) 0.94
CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. PLoS One (2010) 0.92
Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia (2014) 0.91
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination. Exp Neurol (2012) 0.90
Generation of a protective T-cell response following coronavirus infection of the central nervous system is not dependent on IL-12/23 signaling. Viral Immunol (2008) 0.90
Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis. Virology (2008) 0.89
CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination. Autoimmunity (2009) 0.89
Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis. J Neuroimmunol (2009) 0.89
MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination. Stem Cells (2012) 0.89
Measles virus infection induces chemokine synthesis by neurons. J Immunol (2003) 0.89
Chemokine CC receptor 2 is important for acute control of cardiac parasitism but does not contribute to cardiac inflammation after infection with Trypanosoma cruzi. J Infect Dis (2006) 0.87
Chronic spinal cord injury impairs primary antibody responses but spares existing humoral immunity in mice. J Immunol (2012) 0.86
Imaging of acute respiratory distress syndrome. Respir Care (2012) 0.86
Evidence for differential roles for NKG2D receptor signaling in innate host defense against coronavirus-induced neurological and liver disease. J Virol (2007) 0.86
Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation. J Immunol (2011) 0.86
DRAK2 regulates memory T cell responses following murine coronavirus infection. Autoimmunity (2007) 0.86
Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection. Int Immunol (2005) 0.86
Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice. Regen Med (2007) 0.85
Consequences of CXCL10 and IL-6 induction by the murine IFN-alpha1 transgene in ocular herpes simplex virus type 1 infection. Immunol Res (2004) 0.85
Cell replacement therapies to promote remyelination in a viral model of demyelination. J Neuroimmunol (2010) 0.85
Epstein-Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis. J Neuroimmunol (2012) 0.84
Adenovirus-mediated expression of CXCL10 in the central nervous system results in T-cell recruitment and limited neuropathology. J Neurovirol (2003) 0.82
Lack of nitric oxide synthase type 2 (NOS2) results in reduced neuronal apoptosis and mortality following mouse hepatitis virus infection of the central nervous system. J Neurovirol (2002) 0.82
IFN-γ-induced apoptosis of human embryonic stem cell derived oligodendrocyte progenitor cells is restricted by CXCR2 signaling. Stem Cell Res (2012) 0.82
CXCR2 signaling protects oligodendrocyte progenitor cells from IFN-γ/CXCL10-mediated apoptosis. Glia (2011) 0.82
A new tool for sharing and querying of clinical documents modeled using HL7 Version 3 standard. Comput Methods Programs Biomed (2013) 0.81
IFN-gamma-mediated suppression of coronavirus replication in glial-committed progenitor cells. Virology (2008) 0.81
The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System. Curr Immunol Rev (2009) 0.80
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination. J Neuroinflammation (2014) 0.80
Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: a putative marker of disease activity and progression in SPMS. Neuroradiology (2011) 0.80
CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system. Viral Immunol (2007) 0.80
Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis. Stem Cells (2014) 0.79
WSX-1 signalling inhibits CD4⁺ T cell migration to the liver during malaria infection by repressing chemokine-independent pathways. PLoS One (2013) 0.78
Mouse hepatitis virus infection of the CNS: a model for defense, disease, and repair. Front Biosci (2008) 0.78
CXCR2 signaling and host defense following coronavirus-induced encephalomyelitis. Future Virol (2012) 0.77
Intraspinal transplantation of mouse and human neural precursor cells. Curr Protoc Stem Cell Biol (2013) 0.77
The chemokine receptor CXCR2 and coronavirus-induced neurologic disease. Virology (2013) 0.77
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies. Expert Rev Neurother (2014) 0.75
Axonal pathology and demyelination in viral models of multiple sclerosis. Discov Med (2014) 0.75
Nanoparticle induced miscibility in LCST polymer blends: critically assessing the enthalpic and entropic effects. Phys Chem Chem Phys (2015) 0.75
NKG2D signaling and host defense after mouse hepatitis virus infection of the central nervous system. Adv Exp Med Biol (2006) 0.75